Three-Month Interval Maintenance Venom Immunotherapy
نویسندگان
چکیده
1Allergy Related Disease Unit, G d’Annunzio University Foundation, Chieti, Italy 2Department of Medicine and Science of Ageing, Section of Allergy, Clinical Immunology and Occupational Medicine, G d’Annunzio University, Chieti, Italy 3Allergy Unit, Spedali Civili, Brescia, Italy 4Allergy/Pulmonary Rehabilitation Unit, ICP Hospital, Milan, Italy 5Biostatistical Laboratory, Department of Biomedical Sciences, G d’Annunzio University Chieti, Italy
منابع مشابه
Continuous immunotherapy for hymenoptera venom allergy using six month intervals.
BACKGROUND Specific immunotherapy for hymenoptera venom allergy (venom immunotherapy [VIT]) is safe and effective. The duration of treatment is still open for discussion because there is no reliable routine test to determine the real risk of serious anaphylactic reactions. This prospective study, which spans more than 25 years, was conducted to ensure unlimited protection through continuous VIT...
متن کاملEfficacy of venom immunotherapy given every 3 or 4 months: a prospective comparison with the conventional regimen.
BACKGROUND Standard venom immunotherapy involves the administration of the maintenance dose every 4 to 6 weeks. This regimen may have adherence problems, especially in the long term; thus, extended intervals have been proposed. OBJECTIVE We prospectively compared the efficacy of 3- or 4-month extended maintenance dose vs the conventional regimen. METHODS Patients receiving immunotherapy wit...
متن کاملSafety of 100 µg venom immunotherapy rush protocols in children compared to adults
BACKGROUND There is a paucity of studies examining the safety of venom immunotherapy (VIT) in children. We aimed to assess the incidence of anaphylactic side effects during rush VIT in a cohort of pediatric patients and adult controls. METHODS 72 consecutive cycles of VIT-buildup in 71 children/adolescents aged 7-17 years were retrospectively evaluated and compared to an adult control group (...
متن کاملUltrarush immunotherapy in a patient with occupational allergy to bumblebee venom (Bombus terrestris).
Bumblebee venom allergies, though uncommon among the broad public, pose a significant risk in plant industry and scientific occupation. Since a significant IgE cross-reactivity between bumblebee and honeybee venom has been described in several cases and bumblebee venom for immunotherapy has been available only from a few suppliers, SIT with honeybee venom was frequently used for bumblebee venom...
متن کاملLaboratory markers of mast cell and basophil activation in monitoring rush immunotherapy in bee venom-allergic children.
AIM To evaluate markers of mast cell and basophil activation in children undergoing the initial phase of honeybee venom immunotherapy (VIT). PATIENTS & METHODS Five children (four boys and one girl) aged 9.5-18 years with severe systemic bee sting reactions and confirmed IgE-mediated allergy were enrolled. Plasma and urine concentrations of 9α,11β-PGF2 and serum tryptase levels were measured ...
متن کامل